KIMBERLY VAN WYNGARDEN: Open Payments
NPI 1497186472 · TINLEY PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 38 payments from 22 companies in 2025. Trend: 2023 $1,005 · 2024 $859 · 2025 $954
Food & beverage: $858Education: $96
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $118 |
| AstraZeneca Pharmaceuticals LP | 5 | $111 |
| Merck Sharp & Dohme LLC | 4 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| Celgene Corporation | 3 | $73 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| GENZYME CORPORATION | 2 | $41 |
| BeiGene USA, Inc. | 1 | $38 |
| PFIZER INC. | 2 | $37 |
| Daiichi Sankyo Inc. | 1 | $30 |
Products named: Trodelvy, KEYTRUDA, REBLOZYL, KISQALI, ENHERTU, LYNPARZA, CALQUENCE, BRUKINSA.
Industry payments across IL — which companies pay providers there.
